COMMUNIQUÉS West-GlobeNewswire

CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease
10/10/2018
ZUG, Switzerland and BOSTON and CAMBRIDGE, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious [...]
JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
10/10/2018
Approval of Canada’s first Hybrid Closed-Loop System will help Canadians with type 1 diabetes keep their blood sugar levels in an optimal range for a greater amount of time TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- [...]
SuperSonic Imagine will present its new ultrasound platform, the Aixplorer MACH 30, at the French Radiology Days (JFR) from October 12 - 15 in Paris
10/10/2018
AIX-EN-PROVENCE, France, Oct. 10, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI FR0010526814), a company specialised in ultrasound medical imaging, will for the first time present its new Aixplorer MACH 30 [...]
bioAffinity Licenses CyPath® Lung to Precision Pathology Services
10/10/2018
SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued development and [...]
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi® in Combination with Nivolumab in Pancreatic Cancer
10/10/2018
The Phase 2 clinical trial of Tedopi® in pancreatic cancer will be sponsored by the oncology group GERCOR The study will explore Tedopi®’s potential in an additional oncology indication NANTES, France, Oct. 10, 2018 ( [...]
LE GROUPE EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
10/10/2018
LE GROUPE EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME Paris, le 10 octobre 2018 - 17h45 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical [...]
Pharmaceutical Executive Honors Emerging Pharma Leaders
10/10/2018
Awards program recognizes inspiring and distinguished professionals in the industry ISELIN, N.J., Oct. 10, 2018 (GLOBE NEWSWIRE) -- UBM Life Sciences Group’s Pharmaceutical Executive announced honorees of the 2018 [...]
NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call
10/10/2018
WALTHAM, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 third quarter financial results before the opening of the market on Wednesday, October 17 [...]
MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement
10/10/2018
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (" MediPharm ") (TSXV: LABS) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement (the " Agreement ") with Emerald [...]
Imprivata Enters into Agreement with ICU Medical to Improve Security for Infusion Pumps
10/10/2018
LEXINGTON, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced a new collaboration with ICU Medical Inc., a leader in the development, manufacture, and sale of [...]
CO2 GRO is pleased to announce the Appointment of Dr. Matt Julius as Acting Chief Science Officer Effective January 2019
10/10/2018
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“ GROW ” or the “ Company ”) (TSX-V: GROW, OTCQB: BLONF) is pleased to announce that Dr. Matt Julius, Ph.D., Professor of Biology, St. Cloud State [...]
Cannabis Cup Winner Next Green Wave Trading Today -- CFN Media
10/10/2018
SEATTLE, Oct. 10, 2018 (GLOBE NEWSWIRE) -- NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Cannevert To Attend the 7th Annual Masterclass Medicinal Cannabis in Ottawa, Canada
10/10/2018
VANCOUVER, British Columbia, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that Cannevert Therapeutics Ltd.’s ( “ [...]
About acquisition of significant shareholding
10/10/2018
On October 8, 2018, JSC Olainfarm has received a notification from shareholder Nika Saveljeva on increased material shareholding up till 7.80% from share capital with voting rights, since September 7, 2018. The [...]
Segra Engages Canaccord Genuity Corp. for $10 Million Capital Raise Ahead of Going Public, Purchases 20-acre Property for Expansion
10/10/2018
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Segra International Corp. (“ Segra ” or the “ Company [...]
Phoenix Life Sciences International Receives Government Approval to Produce Botanical Pharmaceutical Products in South Pacific
10/10/2018
DENVER, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that the company has [...]
Onconova Therapeutics to Present Update at the 2018 BIO Investor Forum in San Francisco
10/10/2018
NEWTOWN, Pa., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]
Hemispherx Biopharma Signs Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center to Study Ampligen in Combination with Checkpoint Inhibitors in a Phase IIa Study in Urothelial Carcinoma, Renal Cell Carcinoma and Melanoma
10/10/2018
New Agreement Expands Existing Preclinical Collaborations OCALA, Fla., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announces the signing of a clinical trial agreement with Roswell [...]
PSIQ Receives Preliminary Approval From the Kingdom of eSwatini Ministry of Economic Planning and Development to Receive License as the Exclusive Growing Farm and Processing Plant for Medical Cannabis & Hemp in eSwatini
10/10/2018
SUNRISE, Fla., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce preliminary approval from the eSwatini Ministry of Economic Planning and Development to establish an [...]

Pages